Dr Victor J. Dzau is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine (IOM) in the United States. In addition, he serves as Vice Chair of the National Research Council. Dr. Dzau is also James B. Duke Professor of Medicine and Chancellor Emeritus at Duke University and the past President and CEO of the Duke University Health System.
Dr Dzau is recognised globally for a long and highly decorated career as a scientist, administrator and leader. He has made a significant impact on medicine through his seminal research in cardiovascular medicine and genetics and his leadership in health care innovation.
His important work on the renin angiotensin system (RAS) paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as widely used, lifesaving drugs. Dr. Dzau also pioneered gene therapy for vascular disease, and his recent work on stem cell paracrine mechanisms and the use of microRNA in direct reprogramming provides novel insight into stem cell biology and regenerative medicine.
In his role as a leader in health care, Dr. Dzau has led efforts in innovation to improve health, including the development of the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation.
As one of the world’s preeminent health leaders, Dr. Dzau advises governments, corporations, and universities worldwide.